Long-term survival from pembrolizumab (pembro) completion and pembro retreatment: Phase III KEYNOTE-006 in advanced melanoma.

Long, GV; Schachter, J; Arance, A; Grob, JJ; Mortier, L; Daud, A; Carlino, MS; Ribas, A; McNeil, CM; Lotem, M; Larkin, JMG; Lorigan, P; Neyns, B; Blank, CU; Petrella, TM; Hamid, O; Jensen, E; Krepler, C; Diede, SJ; Robert, C

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索